Filing Details
- Accession Number:
- 0001493152-23-036424
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2023-10-05 20:39:03
- Reporting Period:
- 2023-10-02
- Accepted Time:
- 2023-10-05 20:39:03
- Original Submission Date:
- 2023-10-04
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1335105 | Lixte Biotechnology Holdings Inc. | LIXT | Pharmaceutical Preparations (2834) | 202903526 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1939159 | Rene Bernards | Koningsvaren 37 Abcoude P7 1391AD | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-10-02 | 4,473 | $2.29 | 19,473 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2023-10-03 | 5,527 | $2.51 | 25,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The Reporting Person acquired an aggregate of 4,473 shares in numerous trades at prices ranging from $2.29-$2.40
- The Reporting Person acquired an aggregate of 5,527 shares in numerous trades ranging from $2.51-$2.58